ArticleHereditas2025
MiR-4701-3p predicts prognosis of non-small cell lung cancer and regulates cell biological behaviors.
Article in Hereditas, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND &
objectivesNon-small cell lung cancer (NSCLC) represents a malignant neoplasm exhibiting high incidence and mortality rates, marked by diminished patient survival probabilities and an unfavorable prognosis. The primary objective of this research is to investigate the prognostic value of miR-4701-3p in NSCLC and its regulatory role in tumor progression.
methodsIn this study, a cohort comprising 105 patients with NSCLC was enrolled. Expression levels of miR-4701-3p in tissues and cell lines were assayed using RT-qPCR. To investigate the correlation between miR-4701-3p and clinicopathological features, the χ2 test was applied. Additionally, Kaplan-Meier survival analysis alongside Cox regression modeling were performed to evaluate the prognostic significance of miR-4701-3p.
resultsmiR-4701-3p was markedly upregulated in NSCLC tissues and cells. miR-4701-3p was significantly correlated with TNM stage and lymph node metastasis (LNM) in NSCLC patients. The group exhibiting high miR-4701-3p expression demonstrated a markedly decreased 5-year survival rate in comparison to the low expression group. According to Cox regression analysis, miR-4701-3p expression, TNM stage, and lymph node metastasis (LNM) emerged as independent predictors of the 5-year survival rate among NSCLC patients. By downregulating miR-4701-3p, a substantial inhibition of NSCLC cell proliferation, migration, and invasion was observed, accompanied by enhanced apoptotic activity. Conversely, overexpressing miR-4701-3p can enhance cell proliferation, invasion, and migration abilities while inhibiting cell apoptosis.
conclusionThe elevated expression of miR-4701-3p in NSCLC tissues has certain predictive value for poor prognosis in patients and may be involved in malignant behaviors of NSCLC cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.